Endo International plc (NASDAQ: ENDP) announced today that its Par Sterile Products business has begun shipping VASOSTRICT ®, vasopressin injection, USP, in ready-to-use 100 mL pre-mix bottles.

Endo's Par sued Eagle in 2018 after it requested U.S. Food and Drug Administration approval of a generic version of Vasostrict. Chief U.S. District Judge Colm Connolly ruled last year that Eagle ...

Fresenius Kabi USA LLC on Tuesday lost an antitrust lawsuit alleging a subsidiary of rival Endo International PLC ... versions of its blood pressure drug Vasostrict from hitting the market.

Eagle Pharmaceuticals receives FDA approval to sell a generic form of vasopressin, a competitor to ENDP's Vasostrict. This approval follows Eagle's courtroom win in a patent dispute with Endo ...